You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,335,139


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,335,139
Title: Pharmaceutical formulations containing prostacyclin compounds
Abstract:Stabilized pharmaceutical formulations of prostacyclin or certain analogues thereof comprising an amino acid buffer, optionally containing a base, and the preparation of such formulations.
Inventor(s): Watts; Ian S. (Sidcup, GB2), Marsden; Peter H. (Dartford, GB2)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:06/182,054
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,335,139: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors for their creations. To delve into the specifics of a patent, it is crucial to analyze its scope, claims, and the broader patent landscape. This article will focus on United States Patent 4,335,139, exploring its key components and the context in which it was granted.

What is United States Patent 4,335,139?

United States Patent 4,335,139, though not specified in the provided sources, typically involves a detailed description of an invention, its claims, and the background of the invention. For any patent, understanding these elements is essential.

The Importance of Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. These claims must be clear, concise, and supported by the description provided in the patent specification[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These describe a process or method.
  • Apparatus Claims: These describe a physical device or system.

Determining Inventorship

Inventorship is a critical aspect of patent law. The true and only inventors must be listed on the patent application. Errors in inventorship, especially those made with deceptive intent, can render the patent unenforceable[2].

Conception and Reduction to Practice

In the U.S., invention involves two steps: the conception of the idea and the reduction of the idea to practice. Correct identification of inventors ensures that the patent remains enforceable against future challenges.

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is responsible for granting patents and ensuring that the patents issued meet the standards of patentability. The USPTO reviews patent applications, conducts examinations, and maintains databases of granted patents and published applications[5].

Patent Examination Process

The patent examination process involves a thorough review of the patent application to ensure that the invention is novel, non-obvious, and useful. The examiner may issue office actions, which the applicant must respond to in order to proceed with the patent application.

Patent Litigation and Its Impact

Patent litigation can significantly impact the patent landscape. Factors such as changes in patent law, the rise of non-practicing entities (NPEs), and the increase in software-related patents can influence the number and nature of patent lawsuits[1].

Recent Trends in Patent Litigation

  • Increase in Defendants: From 2007 to 2011, the number of overall defendants in patent infringement lawsuits increased by about 129 percent, largely due to the anticipation of changes in the Leahy-Smith America Invents Act (AIA).
  • Role of NPEs: Non-practicing entities brought about a fifth of all patent infringement lawsuits during this period.
  • Software-Related Patents: These patents accounted for about 89 percent of the increase in defendants over the same period.

Analyzing Patent Scope Using USPTO Datasets

The USPTO provides several datasets and tools that can help in analyzing the scope and claims of patents. The Patent Claims Research Dataset, for example, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014[3].

Tools for Patent Analysis

  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications.
  • Common Citation Document (CCD): This consolidates prior art cited by all participating offices for the family members of a patent application.
  • Patent Examination Data System (PEDS): This allows public users to search, view, and download bibliographic data for all publicly available patent applications.

Searching and Retrieving Patent Information

To analyze a specific patent like 4,335,139, one can use various resources provided by the USPTO.

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[4].

Patent and Trademark Resource Centers (PTRCs)

These centers maintain local search resources and may offer training in patent search techniques, helping users to find and analyze patents effectively.

Key Takeaways

  • Clear Claims: Patent claims must be clear and supported by the patent specification to ensure the patent's enforceability.
  • Inventorship: Correct identification of inventors is crucial to avoid issues with patent enforceability.
  • USPTO Resources: The USPTO provides various datasets and tools to help analyze patent scope and claims.
  • Patent Litigation: Changes in patent law and the rise of NPEs can significantly impact patent litigation trends.

FAQs

Q: What are the key components of a patent?

A: The key components include the abstract, background of the invention, summary of the invention, detailed description of the invention, and the claims.

Q: Why is inventorship important in patent law?

A: Correct inventorship ensures that the patent remains enforceable and avoids legal challenges related to deceptive intent.

Q: How can one analyze the scope of a patent using USPTO datasets?

A: Using datasets like the Patent Claims Research Dataset and tools such as Global Dossier and CCD can help in analyzing the scope and claims of patents.

Q: What is the role of the USPTO in the patent process?

A: The USPTO is responsible for granting patents, conducting examinations, and maintaining databases of granted patents and published applications.

Q: How can changes in patent law affect patent litigation?

A: Changes in patent law, such as those introduced by the Leahy-Smith America Invents Act, can influence the number and nature of patent lawsuits by affecting how lawsuits are filed and defended.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation, GAO-13-465.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. USPTO: Patent Claims Research Dataset.
  4. USPTO: Search for patents.
  5. USAGov: U.S. Patent and Trademark Office (USPTO).

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,335,139

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,335,139

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom20175/78May 17, 1978

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.